TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Capital expenditures (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $1.7B | +20.4% | 0.7% | 13.7% |
| Capital expenditures (TTM) | $1.7B |
|---|---|
| YoY | +20.4% |
| 5-year CAGR | 0.7% |
| 10-year CAGR | 13.7% |
Capital expenditures
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.5B | +8.9% |
| 2024 | $1.4B | −5.3% |
| 2023 | $1.5B | −34.1% |
| 2022 | $2.2B | −11.1% |
| 2021 | $2.5B | +71.2% |
| 2020 | $1.5B | +59.2% |
| 2019 | $926M | +22.2% |
| 2018 | $758M | +49.2% |
| 2017 | $508M | +14.4% |
| 2016 | $444M | +5.0% |
| 2015 | $423M | −1.1% |
| 2014 | $428M | +51.4% |
| 2013 | $282M | −10.4% |
| 2012 | $315M | +20.8% |
| 2011 | $261M | +6.3% |
| 2010 | $245M | +22.7% |
| 2009 | $200M | −24.4% |
| 2008 | $264M | +50.7% |
| 2007 | $176M | — |